Interestingly, TIGIT+ CD4+ T-cells produced higher amounts of IFNγ and IL-10 in a TIGIT-dependent manner than their TIGIT- counterparts [8], which is in line with the aforementioned beneficial effects of IFNγ on CLL cells in vitro. Here, TIGIT is linked to B-cell chronic lymphocytic leukemia.